GlassScriptPhysician profile
Scott M Hane
NPI 1780611442
$480.04
in general payments reported to CMS, 2019-2025
17 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $452 · 2022: $27.78.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $72.52 | 2019-2022 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $54.31 | 2019 | |
| Novo Nordisk INC | $46.03 | 2019 | |
| Lilly USA, LLC | $45.74 | 2019 | |
| Takeda Pharmaceuticals U.S.A., INC. | $41.68 | 2019 | |
| Pfizer INC. | $33.32 | 2019 | |
| Supernus Pharmaceuticals, INC. | $24.52 | 2019 | |
| Horizon Therapeutics Plc | $23.73 | 2019 | |
| Janssen Pharmaceuticals, INC | $23.69 | 2019 | |
| Astellas Pharma US INC | $18.25 | 2019 | |
| Zyla Life Sciences, INC. | $17.90 | 2019 | |
| Novartis Pharmaceuticals Corporation | $14.90 | 2019 | |
| Genentech USA, INC. | $13.76 | 2019 | |
| Glaxosmithkline, LLC. | $13.40 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $12.29 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Tris Pharma INC | $12.22 | 2019 | |
| Merck Sharp & Dohme LLC | $11.78 | 2019 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Hane listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.